4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Biofrontera Inc. (BFRI) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Woburn, United States with about 84 employees. Its market capitalization is roughly $14 million. In the fiscal year ended 2025-12-31, BFRI reported $42M in revenue and ($10M) in net income.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Interactive charts & full statements → Open the BFRI valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $42M | $37M | $34M | $29M | — |
| Gross Profit | $31M | $19M | $17M | $14M | — |
| Operating Income (EBIT) | ($11M) | ($17M) | ($23M) | ($22M) | — |
| Net Income | ($10M) | ($18M) | ($20M) | ($1M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $10M | $17M | $7M | $9M | $9M | — |
| Gross Profit | $8M | $14M | $5M | $6M | $5M | — |
| Operating Income (EBIT) | ($4M) | $5M | ($6M) | ($5M) | ($4M) | — |
| Net Income | ($5M) | $6M | ($7M) | ($5M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $29M | $22M | $28M | $51M | — |
| Total Liabilities | $18M | $18M | $23M | $27M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BFRI viewer.
About TickerBase · Data methodology & sources